Jasper Therapeutics announces special shareholder meeting

• Jasper Therapeutics will hold a virtual special shareholder meeting on Sept. 30, 2026.
• Vote on a reverse stock split within a 1-for-15 to 1-for-35 range, with the final ratio set by the board.
• Consider an increase in authorized common shares to 675,000,000 from 490,000,000.
• Ballot also includes potential adjournment to seek additional support for the reverse split or the authorized-share increase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-093145), on August 24, 2026, and is solely responsible for the information contained therein.